Defence News NG
Foreign

Trial of a Chinese COVID-19 vaccine in Russia: ‘No side effects’

People who got a Chinese COVID-19 vaccine candidate in a large-scale clinical trial in Moscow in early September have reported no side effects, local media the Moscow Times reported Monday.

The vaccine, called Ad5-nCoV, was developed by Chinese company CanSino Biologics in alliance with the Chinese military’s research arm.

Russia approved the Phase III trial of the vaccine last month, and Russian pharmaceutical company Petrovax worked with CanSino to conduct the trial. Petrovax said it has received more than 3,000 applications to get the vaccine so far.

“At the moment, the volunteers are doing well. None of them have shown any side effects,” Petrovax said in a press release.

The study participants who got vaccinated are expected to develop antibodies and cellular immune response to COVID-19, the company said.

They will be put under direct supervision for nearly a month, with four interim face-to-face examinations, and will undergo a control examination after six months, according to Petrovax.

The preliminary results are expected to come out in November, it said.

Once the vaccine is approved to enter the market after reliable results from the Phase III trial, Petrovax said it will be able to produce more than four million doses per month this year and 10 million doses per month in 2021.

CanSino’s Ad5-nCoV is one of the most promising COVID-19 candidates currently in the final stage of clinical trials worldwide. The Phases I and II trails, which involved more than 700 volunteers, were conducted in China this spring, all showing good results.

Phase III trial of the vaccine has also launched in Saudi Arabia, involving about 5,000 subjects, according to CanSino.

Russia has already registered one of its self-developed COVID-19 vaccines – Sputnik V – last month just after Phases I and II trails, although its long-term safety and effectiveness remained to be tested in Phase III trials involving 40,000 participants.

Also Check Out:

Tianjin attracts high-level talents with high-quality development

Defence News Ng

Intelligent weather forecast helps prevent, alleviate natural disasters

Defence News Ng

The Unforgotten War: President Xi urges Chinese people to carry forward spirit of ‘War to Resist US Aggression and Aid Korea’

Defence News Ng

Photovoltaic power stations in NW China’s Qinghai province help local villagers secure livelihood

Defence News Ng

India bans TikTok, WeChat among dozens of other China-linked apps

Defence News Ng

U.S. attempts to interfere in China’s domestic affairs will never succeed

Defence News Ng

China establishes monitoring and assistance mechanism to prevent reoccurrence of poverty

Defence News Ng

China, Russia enhance strategic coordination in sci-tech innovation

Defence News Ng

Chinese mainland reports 9 new confirmed COVID-19 cases, all imported

Defence News Ng

Peng Liyuan addresses SCO forum on women’s education, poverty alleviation

Defence News Ng

Chinese SMEs seeks opportunities through digital transformation

Defence News Ng

Saudi Arabia wades in on French cartoon debate as row escalates

Defence News Ng

Leave a Comment